Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy)
✍ Scribed by Annekatrin Lukanova; Eva Lundin; Andrea Micheli; Arslan Akhmedkhanov; Sabina Rinaldi; Paola Muti; Per Lenner; Carine Biessy; Vittorio Krogh; Elio Riboli; Göran Hallmans; Franco Berrino; Anne Zeleniuch-Jacquotte; Paolo Toniolo; Rudolf Kaaks
- Book ID
- 110440062
- Publisher
- Springer Netherlands
- Year
- 2003
- Tongue
- English
- Weight
- 103 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Higher levels of circulating Insulin‐like Growth Factor (IGF)‐I may be associated with higher risks for premenopausal breast cancer. We investigate the associations between circulating levels of IGF‐I, its binding proteins (IGFBPs) ‐1, ‐2, ‐3, C‐peptide and postmenopausal breast cancer.
## Abstract The physical inactivity and obesity involved in hyperglycemia and hyperinsulinemia is supposed to lead to an increased bioavailability of insulin‐like growth factor‐I (IGF‐I). The carcinogenic effect of IGF‐I may be influenced by IGF binding proteins. We investigated the association bet
Insulin-like growth factor-I (IGF-I) has mitogenic and anti-apoptotic properties and has been implicated in the development of breast, colorectum, prostate and lung cancer. IGF binding proteins (IGFBPs) are not only carrier proteins for IGFs but also hold a central position in IGF ligand-receptor in